10q10k10q10k.net
MIMEDX GROUP, INC.

MIMEDX GROUP, INC.MDXGEarnings & Financial Report

Nasdaq

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

NextFeb 27, 2026

MDXG Q3 2025 Key Financial Metrics

Revenue

$113.7M

Gross Profit

$95.0M

Operating Profit

$22.2M

Net Profit

$16.7M

Gross Margin

83.5%

Operating Margin

19.5%

Net Margin

14.7%

YoY Growth

35.3%

EPS

$0.11

Financial Flow

MIMEDX GROUP, INC. Q3 2025 Financial Summary

MIMEDX GROUP, INC. reported revenue of $113.7M for Q3 2025, with a net profit of $16.7M (14.7% margin). Cost of goods sold was $18.7M, operating expenses totaled $72.8M.

Key Financial Metrics

Total Revenue$113.7M
Net Profit$16.7M
Gross Margin83.5%
Operating Margin19.5%
Report PeriodQ3 2025

MIMEDX GROUP, INC. Annual Revenue by Year

MIMEDX GROUP, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $348.9M).

YearAnnual Revenue
2024$348.9M
2023$321.5M
2022$267.8M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$86.8M$84.7M$87.2M$84.1M$92.9M$88.2M$98.6M$113.7M
YoY Growth16.7%18.2%7.3%2.9%7.0%4.1%13.1%35.3%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$239.0M$221.7M$230.2M$243.9M$263.9M$270.4M$291.1M$319.0M
Liabilities$96.3M$66.0M$62.1M$62.9M$70.8M$67.6M$74.5M$80.0M
Equity$142.7M$155.7M$168.0M$181.0M$193.1M$202.8M$216.6M$238.9M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$10.3M$6.0M$21.8M$19.6M$18.8M$5.3M$14.4M$29.3M